Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company SiteOne Therapeutics Inc.
DescriptionLong-acting injectable muscle relaxant
Molecular Target Nav1.4 (SCN4A)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationPain
Indication DetailsReduce pain and spasticity
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today